Marc Mezvinsky

Marc Mezvinsky (born December 10, 1977) is an American investor and managing director at TPG. He has served previously as vice chairman at Social Capital. He is the husband of Chelsea Clinton, daughter of former President Bill Clinton and former Secretary of State Hillary Clinton. Mezvinsky was born in Philadelphia, Pennsylvania, and grew up attending a Conservative Jewish synagogue and Friends' Central School, a Quaker school outside of Philadelphia. His parents are both former Democratic members of the U.S. House of Representatives. His father is Edward Mezvinsky (b. 1937) and his mother is Marjorie Margolies (b. 1942). Mezvinsky has 10 brothers and sisters, including five adopted siblings. His mother wrote a book, They Came to Stay, about her experiences adopting children from Korea and Vietnam as a single woman. The Mezvinskys took a number of refugee families into their home and arranged surgeries and adoptions for distressed children from abroad. Mezvinsky graduated from Stanford University in 2000, earning a BA in religious studies and philosophy. He then attended Pembroke College, Oxford, where he received his MA in Politics, Philosophy and Economics. Mezvinsky first met Chelsea Clinton as a teenager at a 1993 Democratic political retreat in Hilton Head, South Carolina as Mezvinsky's parents had both been members of Congress and were friends with the Clintons in the 1990s. They were first reported to be a couple in 2005, and became engaged in 2009. In July 2010, Mezvinsky married Chelsea Clinton in an interfaith ceremony in Rhinebeck, New York. On September 26, 2014, Chelsea Clinton gave birth to their daughter Charlotte Clinton Mezvinsky. On June 18, 2016, Clinton gave birth to their son Aidan Clinton Mezvinsky. On July 22, 2019, she gave birth to their second son, Jasper Clinton Mezvinsky. Mezvinsky serves on the board of the Pembroke College Foundation and the Ann Romney Center for Neurologic Diseases, an organization dedicated to transforming the future of medicine through collaboration and patient-centered research.